The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial

Abstract

Some of the data in this paper by Wu and colleagues ( BMJ 2025;388:e082583, doi:10.1136/bmj-2024-082583, published 15 January 2025) have been updated. Disruptions to clinical service during the covid-19 pandemic affected the data verification process at some of the trial centres leading to inaccurate data being entered …